SCHEMBL22177552

SCHEMBL22177552

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4cccc5oc6cccc(-c7nc8ccccc8s7)c6c45)n3)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 9/20 0.45
▸ MAPT P10636 6/20 0.45
▸ NPC1 O15118 6/20 0.45
▸ ALDH1A1 P00352 5/20 0.45
▸ KDM4E B2RXH2 5/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ SMN1; SMN2 Q16637 4/20 0.45
▸ APP P05067 3/20 0.45
▸ GAA P10253 3/20 0.45
▸ L3MBTL1 Q9Y468 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ MMP9 P14780 1/20 0.45
▸ MMP8 P22894 1/20 0.45
▸ NFKB1 P19838 3/20 0.42
▸ NFKB2 Q00653 3/20 0.42
▸ RELA Q04206 3/20 0.42
▸ LMNA P02545 2/20 0.42
▸ PAX8 Q06710 1/20 0.42
▸ NOD2 Q9HC29 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22177219 1.00 RAB9A (0.45) RAB9AMAPTNPC1ALDH1A1KDM4E
SCHEMBL22177553 0.97 RAB9A (0.47) RAB9AMAPTNPC1ALDH1A1KDM4E
SCHEMBL22177217 0.96 APP (0.44) RAB9AMAPTNPC1ALDH1A1KDM4E
SCHEMBL22177981 0.96 APP (0.50) RAB9AMAPTNPC1ALDH1A1KDM4E
SCHEMBL22177551 0.95 RAB9A (0.43) RAB9AMAPTNPC1ALDH1A1KDM4E
SCHEMBL22177976 0.94 RAB9A (0.42) RAB9AMAPTNPC1ALDH1A1KDM4E
SCHEMBL22177656 0.93 APP (0.49) RAB9AMAPTNPC1ALDH1A1KDM4E
SCHEMBL22177596 0.92 RAB9A (0.42) RAB9AMAPTNPC1ALDH1A1KDM4E
SCHEMBL22177657 0.92 APP (0.50) RAB9AMAPTNPC1ALDH1A1KDM4E
SCHEMBL22177609 0.92 RAB9A (0.44) RAB9AMAPTNPC1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same LG CHEM, LTD. (KR) 2022-12-06 — — US disclosed
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2020-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200207754-A1 NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, CRY2, CYP1A1 RAB9A 2411/4885MAPT 1997/4885NPC1 2337/4885
US-11518769-B2 Heterocyclic compounds and organic light emitting device using the same CRY1, CYP1A1, CRY2 RAB9A 2545/4885MAPT 1660/4885NPC1 2044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback